MedTrace Logo

Sodium Creatine Phosphate in Heart Valve Surgery

NCT03186053 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2018-01-31

No results posted yet for this study

Summary

To explore the effect of intraoperative sodium creatine phosphate on myocardial protection in patients undergoing valve surgery

Conditions

  • Heart Valve Diseases

Interventions

DRUG

sodium creatine phosphate

sodium creatine phosphate .Loading dose followed by continuous infusion in operation

DRUG

saline

.Loading dose followed by continuous infusion in operation

Sponsors & Collaborators

  • Chinese Academy of Medical Sciences, Fuwai Hospital

    lead OTHER

Principal Investigators

  • Guyan WANG, M.D. · Department of anesthesiology,Fuwai hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-15
Primary Completion
2018-07-01
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03186053 on ClinicalTrials.gov